Kazia Therapeutics Ltd (KZIA)
5.30
-0.40
(-7.02%)
USD |
NASDAQ |
Nov 14, 16:00
5.27
-0.03
(-0.57%)
After-Hours: 20:00
Kazia Therapeutics Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 16.79M |
| November 12, 2024 | 19.09M |
| November 11, 2024 | 20.38M |
| November 08, 2024 | 16.92M |
| November 07, 2024 | 17.32M |
| November 06, 2024 | 19.12M |
| November 05, 2024 | 18.22M |
| November 04, 2024 | 19.72M |
| November 01, 2024 | 16.19M |
| October 31, 2024 | 15.79M |
| October 30, 2024 | 16.72M |
| October 29, 2024 | 15.76M |
| October 28, 2024 | 13.33M |
| October 25, 2024 | 15.13M |
| October 24, 2024 | 15.39M |
| October 23, 2024 | 17.10M |
| October 22, 2024 | 16.75M |
| October 21, 2024 | 16.51M |
| October 18, 2024 | 14.54M |
| October 17, 2024 | 15.36M |
| October 16, 2024 | 8.915M |
| October 15, 2024 | 8.805M |
| October 14, 2024 | 11.22M |
| October 11, 2024 | 11.33M |
| October 10, 2024 | 11.23M |
| Date | Value |
|---|---|
| October 09, 2024 | 11.00M |
| October 08, 2024 | 12.00M |
| October 07, 2024 | 11.64M |
| October 04, 2024 | 12.47M |
| October 03, 2024 | 12.08M |
| October 02, 2024 | 12.34M |
| October 01, 2024 | 12.16M |
| September 30, 2024 | 12.13M |
| September 27, 2024 | 10.94M |
| September 26, 2024 | 9.947M |
| September 25, 2024 | 8.702M |
| September 24, 2024 | 8.678M |
| September 23, 2024 | 8.948M |
| September 20, 2024 | 8.625M |
| September 19, 2024 | 8.812M |
| September 18, 2024 | 9.134M |
| September 17, 2024 | 8.475M |
| September 16, 2024 | 9.134M |
| September 13, 2024 | 9.238M |
| September 12, 2024 | 9.351M |
| September 11, 2024 | 9.990M |
| September 10, 2024 | 9.987M |
| September 09, 2024 | 10.40M |
| September 06, 2024 | 10.18M |
| September 05, 2024 | 11.46M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-3.429M
Minimum
Dec 28 2022
171.31M
Maximum
Apr 08 2021
46.93M
Average
23.11M
Median
Dec 13 2019
Enterprise Value Benchmarks
| Alterity Therapeutics Ltd | -- |
| Immutep Ltd | -- |
| Opthea Ltd | 544.62M |
| Mesoblast Ltd | -- |
| Immuron Ltd | 3.484M |